SUBSCRIBE
SUBSCRIBE
News   Business

Entelos, Inc. Enters Research Deal with UCB Pharma in Rheumatoid Arthritis

January 21, 2008 | 
1 min read
LONDON (Thomson Financial) - Entelos Inc said it has signed a research deal with UCB Pharma S A to conduct in silico research in the field of rheumatoid arthritis using the Entelos Rheumatoid Arthritis PhysioLab platform.
Alliances Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BioAtla Cuts Some 70% of Workforce as Company Considers Options
March 3, 2026
 · 
60 min read
 · 
BioSpace Editorial Staff
Set of crumpled lumps of different paper isolated on yellow background. Gritty dusty dotted effect, vector elements with jagged edges, old notebook sheets.
MASH
Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration showing line of people leaving, standing on top of hand pointing their way out
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
 · 
1 min read
 · 
Angela Gabriel
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac